These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24722261)

  • 1. A novel blood-sparing agent in cardiac surgery? First in-patient experience with the synthetic serine protease inhibitor MDCO-2010: a phase II, randomized, double-blind, placebo-controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Englberger L; Dietrich W; Eberle B; Erdoes G; Keller D; Carrel T
    Anesth Analg; 2014 Jul; 119(1):16-25. PubMed ID: 24722261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
    Casati V; Della Valle P; Benussi S; Franco A; Gerli C; Baili P; Alfieri O; D'Angelo A
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):83-91. PubMed ID: 15224025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ; Nielsen C
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting.
    Troianos CA; Sypula RW; Lucas DM; D'Amico F; Mathie TB; Desai M; Pasqual RT; Pellegrini RV; Newfeld ML
    Anesthesiology; 1999 Aug; 91(2):430-5. PubMed ID: 10443606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting.
    Santos AT; Kalil RA; Bauemann C; Pereira JB; Nesralla IA
    Braz J Med Biol Res; 2006 Jan; 39(1):63-9. PubMed ID: 16400465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial.
    Brown RS; Thwaites BK; Mongan PD
    Anesth Analg; 1997 Nov; 85(5):963-70. PubMed ID: 9356085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
    Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
    Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin.
    Greilich PE; Brouse CF; Whitten CW; Chi L; Dimaio JM; Jessen ME
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1498-503. PubMed ID: 14666025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery.
    Shore-Lesserson L; Reich DL; Vela-Cantos F; Ammar T; Ergin MA
    Anesth Analg; 1996 Jul; 83(1):18-26. PubMed ID: 8659732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
    Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA
    Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization.
    Mongan PD; Brown RS; Thwaites BK
    Anesth Analg; 1998 Aug; 87(2):258-65. PubMed ID: 9706913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
    Kikura M; Levy JH; Tanaka KA; Ramsay JG
    J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel blood-sparing agent in cardiac surgery: do we need another agent?
    Faraoni D; Levy JH
    Anesth Analg; 2014 Jul; 119(1):11-12. PubMed ID: 24945119
    [No Abstract]   [Full Text] [Related]  

  • 16. Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study.
    Tobe CE; Vocelka C; Sepulvada R; Gillis B; Nessly M; Verrier ED; Hofer BO
    J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1007-13; discussion 1013-4. PubMed ID: 8501929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Wang G; Xie G; Jiang T; Wang Y; Wang W; Ji H; Liu M; Chen L; Li L
    Anesth Analg; 2012 Aug; 115(2):239-43. PubMed ID: 21737704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose tranexamic acid effect on post-coronary artery bypass grafting bleeding.
    Esfandiari BR; Bistgani MM; Kabiri M
    Asian Cardiovasc Thorac Ann; 2013 Dec; 21(6):669-74. PubMed ID: 24569324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.